COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 647: Articles 6461-6470  | Next

Food Insecurity During the First Year of COVID-19: An Analysis of Employment and Sociodemographic Factors Among a Longitudinal Cohort (CHASING COVID)
Ng, Y., Chang, M., Robertson, M., Grov, C., Maroko, A., Zimba, R., Westmoreland, D., Rane, M., Mirzayi, C., Parcesepe, A. M., Kulkarni, S., Salgado-You, W., Cohen, N., Nash, D.
10.1101/2022.09.20.22280094 — Posted: 2022-09-21
Exploring the relationship between job characteristics and infection: Application of a COVID-19 Job Exposure Matrix to SARS-CoV-2 infection data in the United Kingdom
Rhodes, S., Beale, S., Wilkinson, J., Van-Veldhoven, K., Basinas, I., Mueller, W., Oedehengel, K., Burdorf, A., Peters, S., Stokholm, Z., Schlunssen, V., Kolstad, H., Pronk, A., Pearce, N., Hayward, A., van Tongeren, M.
10.1101/2022.09.21.22280191 — Posted: 2022-09-21
Prevalence of SARS-CoV-2 and co-occurrence/co-infection with malaria during the first wave of the pandemic (the Burkina Faso case)
Lopez-Farfan, D. C., Yerbanga, R. S., Parres-Mercader, M., Torres-Puente, M., Gomez-Navarro, I., Sanou, D. M. S., Yao, A. F., Ouedraogo, J. B., Comas, I., Irigoyen, N., Gomez-Diaz, E.
10.1101/2022.09.20.22280138 — Posted: 2022-09-20
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Gupta, A., Konnova, A., Smet, M., Berkell, M., Savoldi, A., Morra, M., Van averbeke, V., De Winter, F., Peserico, D., Danese, E., Hotterbeekx, A., Righi, E., mAb ORCHESTRA working group, , De Nardo, P., Tacconelli, E., Malhotra-Kumar, S., Kumar-Singh, S.
10.1101/2022.09.20.22280135 — Posted: 2022-09-20
Responding to disruption: Exploring the transition to telehealth in mental-health occupational therapy during the COVID-19 pandemic
Duffy, A., Boyle, B., Gorman, E., Hayes, S.
10.1101/2022.09.19.22280127 — Posted: 2022-09-20
PrimedSherlock: A tool for rapid design of highly specific CRISPR-Cas12 crRNAs
Pitts, R. J., Mann, J. G.
10.1101/2022.09.19.508610 — Posted: 2022-09-20
Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
Starr, T. N., Greaney, A. J., Stewart, C. M., Walls, A. C., Hannon, W. W., Veesler, D., Bloom, J. D.
10.1101/2022.09.20.508745 — Posted: 2022-09-20
Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?
Furuzawa-Carballeda, J., Icaza-Chavez, M. E., Aguilar-Leon, D., Uribe-Uribe, N., Nunez-Pompa, M. C., Trigos-Diaz, A., Arean-Sanz, R., Fernandez-Camargo, D. A., Coss-Adame, E., Valdovinos, M. A., Briceno-Souza, E., Chi-Cervera, L. A., Olivares-Flores, M., Torres-Villalobos, G.
10.1101/2022.09.19.22280068 — Posted: 2022-09-20
The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
Thompson, R. N., Southall, E., Daon, Y., Lovell-Read, F. A., Iwami, S., Thompson, C. P., Obolski, U.
10.1101/2022.09.20.22280161 — Posted: 2022-09-20
Age-Associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
Yam-Puc, J. C., Hosseini, Z., Horner, E. C., Gerber, P. P., Beristain-Covarrubias, N., Hughes, R., Rust, M., Boston, R., Ali, M., Simmons Rosello, E., O'Reilly, M., Robson, H., Booth, L. H., Kahanawita, L., Grigoriadou, S., Correa-Noguera, A., Ceron-Guiterez, L., Mulroney, T., Lulla, A., Fischer, K., Craxton, A., Anderson, G. S., Sun, X.-M., Elmer, A., Saunders, C., Bermperi, A., Jose, S., Chapman, M., MacFarlane, M., Willis, A. E., Patil, K. R., Hollfelder, F., Hyvonen, M., CITIID-NIHR COVID-19 BioResource Collaboration, , Spencer, S., Staples, E., Buckland, M. S., Doffinger, R., Parkinson, C., Lear, S., Matheson, N. J., Thaventhiran, J. E.
10.1101/2022.09.17.22280033 — Posted: 2022-09-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).